Pepdox
Studies
Peptides
Calculator
A RESPONSE TO: "COST-EFFECTIVENESS OF ORAL SEMAGLUTIDE ADDED TO CURRENT ANTIHYPERGLYCEMIC TREATMENT FOR TYPE 2 DIABETES". | Pepdox
Home
/
Search
/
PMID 34337999
A RESPONSE TO: "COST-EFFECTIVENESS OF ORAL SEMAGLUTIDE ADDED TO CURRENT ANTIHYPERGLYCEMIC TREATMENT FOR TYPE 2 DIABETES".
Journal of managed care & specialty pharmacy
2021
PMID: 34337999
View on PubMed
DOI: 10.18553/jmcp.2021.27.8.1140
Semaglutide
Authors
Kohli-Lynch, Ciaran N; Ruiz-Negrón, Natalia; Beal, Amy; Bellows, Brandon K